Niki BioSolutions, Inc. NIKI
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.64M | 1.48M | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -170.90K | 68.00K | -- | -- | -- |
| Total Operating Expenses | 1.82M | 1.52M | -- | -- | -- |
| Operating Income | -1.82M | -1.52M | -- | -- | -- |
| Income Before Tax | -1.38M | -1.84M | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.38 | -1.84 | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 13.20K | -139.40K | -- | -- | -- |
| Net Income | -1.36M | -1.98M | -- | -- | -- |
| EBIT | -1.82M | -1.52M | -- | -- | -- |
| EBITDA | -1.56M | -1.27M | -- | -- | -- |
| EPS Basic | -1.86 | -3.12 | -- | -- | -- |
| Normalized Basic EPS | -1.16 | -1.10 | -- | -- | -- |
| EPS Diluted | -1.88 | -3.14 | -- | -- | -- |
| Normalized Diluted EPS | -1.16 | -1.10 | -- | -- | -- |
| Average Basic Shares Outstanding | 2.94M | 2.70M | -- | -- | -- |
| Average Diluted Shares Outstanding | 2.94M | 2.70M | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |